Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study von Huang, Yu-Huei, Tang, Chao-Hsiun, Goh, Choo Hua, Chang, Chia-Li, Qiu, Hong, Yang, Ya-Wen, Saadoun, Carine, Chang, Chia-Ling, Liu, Yanfang

Volltext

Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2 von Kim, Byung Soo, Jo, Seong Jin, Youn, SangWoong, Reich, Kristian, Saadoun, Carine, Chang, Chia-Ling, Yang, Ya-Wen, Huang, Yu-Huei, Tsai, Tsen-Fang

Volltext

A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan von Liu, Yanfang, Goh, Choo Hua, Qiu, Hong, Huang, Kuan-Chih, Chung, Hsingwen, Saadoun, Carine

Volltext

Efficacy of guselkumab in difficult‐to‐treat psoriasis regions: Data from VOYAGE 1 and VOYAGE 2 Asian subpopulations von Jo, Seong Jin, Huang, Yu‐Huei, Tsai, Tsen‐Fang, Kim, Byung Soo, Reich, Kristian, Saadoun, Carine, Chang, Chia‐Ling, Yang, Ya‐Wen, Youn, Sang Woong

Volltext

Early non-response to certolizumab pegol in rheumatoid arthritis predicts treatment failure at one year. Data from a randomised phase III clinical trial von Berenbaum, Francis, Pham, Thao, Claudepierre, Pascal, de Chalus, Thibault, Joubert, Jean-Michel, Saadoun, Carine, Riou França, Lionel, Fautrel, Bruno

Volltext

Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France von Fagnani, Francis, Pham, Thao, Claudepierre, Pascal, Berenbaum, Francis, De Chalus, Thibault, Saadoun, Carine, Joubert, Jean-Michel, Fautrel, Bruno

Volltext